Literature DB >> 20166544

[Adult case of severe Henoch-Schönlein purpura associated with steroid-resistant nephrotic syndrome successfully treated with intravenous cyclophosphamide].

Tomoko Namba1, Takeshi Yamamoto, Jun Matsuda, Hiroyuki Kadoya, Masanobu Takeji, Atsushi Yamauchi.   

Abstract

Henoch-Schönlein purpura (HSP) is a systemic disorder characterized by small vessel vasculitis with the deposition of IgA immune complexes. Renal involvement is the major cause of morbidity and mortality in patients with HSP. We report here a 37-year-old female patient with HSP nephritis (HSPN) associated with steroid-resistant nephrotic syndrome and renal dysfunction despite conventional therapy. The patient was successfully treated with intravenous cyclophosphamide following treatment with intravenous pulse methylprednisolone and oral prednisolone. The combination therapy resulted in a significant decrease in proteinuria, together with improvement of renal function. The patient finally reached a stage of clinical remission.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20166544

Source DB:  PubMed          Journal:  Nihon Jinzo Gakkai Shi        ISSN: 0385-2385


  2 in total

1.  An adult case of severe steroid-resistant Henoch-Schönlein purpura nephritis treated with intravenous cyclophosphamide and tonsillectomy.

Authors:  Emi Sasaki; Maki Shibata; Asami Kato; Naoto Hamano; Takashi Katsuki; Manami Tada; Fumihiko Hinoshita
Journal:  CEN Case Rep       Date:  2016-07-13

2.  Methylprednisolone pulse therapy and intravenous cyclophosphamide therapy combined with cocktail therapy in severe pediatric Henoch-Schönlein purpura nephritis patient.

Authors:  Hiroaki Kanai; Anna Kobayashi; Kyoko Matsushita; Emi Sawanobori; Kanji Sugita; Kosuke Higashida
Journal:  CEN Case Rep       Date:  2013-01-12
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.